Abstract: This application provides a screen casting method, a device, and a storage medium. In a screen casting process, when a sound output device is switched to the screen casting transmit end, whether the screen casting transmit end outputs a sound depends on a current status of an audio status switching control, thereby ensuring that whether the screen casting transmit end outputs a sound can be consistent with an expectation of a user in a screen casting scenario. In addition, in the screen casting method provided in this application, when whether the screen casting transmit end outputs a sound is set based on a click operation performed by the user on the audio status switching control, an icon corresponding to the audio status switching control is dynamically modified based on an audio status (mute or non-mute) corresponding to the audio status switching control.

Abstract: Disclosed embodiments provide techniques for monitoring and evaluating the effectiveness of key value pairs (KVPs) used in a document processing system. In embodiments, KVPs are obtained from multiple extractors of a document processing system. A score is computed for the KVPs by computing an effectiveness metric for each KVP from the multiple KVPs. In response to the computed score being below a predetermined threshold, a model retraining process is performed to generate a new set of KVP extractors, and provide the new set of KVPs to the document processing system.

Abstract: Disclosed embodiments provide techniques for monitoring and evaluating the effectiveness of key value pairs (KVPs) used in a document processing system. In embodiments, KVPs are obtained from multiple extractors of a document processing system. A score is computed for the KVPs by computing an effectiveness metric for each KVP from the multiple KVPs. In response to the computed score being below a predetermined threshold, a model retraining process is performed to generate a new set of KVP extractors, and provide the new set of KVPs to the document processing system.

Abstract: A system, method, and computer program product are configured to extract key value pair (KVP) data from one or more documents; obtain a content index for the one or more documents; and enhance the content index with the KVP data to provide a KVP content index.

Abstract: Provided is an intelligent control-based dosing and stirring device for sediment pollution control, including a support underframe, a support frame, a chemical cartridge, and a stirring assembly which works through intelligent control. A support ring positioned in a middle position is fixed into the support underframe by multiple support rods, and an anti-shaking mechanism is arranged in the support ring, and mounted in the support ring by multiple shock-absorbing assemblies. The shock-absorbing assemblies are used for shock absorption, thus preventing the chemical cartridge from shaking. The anti-shaking mechanism includes a circular support block, and an annular groove is formed in the circular support block. The intelligent control-based dosing and stirring device for sediment pollution control relates to the technical field of dosing and stirring devices.

Abstract: The disclosure relates to stable RSV F proteins and immunogenic compositions containing the same, as well as methods of using the immunogenic compositions and compositions comprising the RSV F proteins.

Abstract: Disclosed embodiments provide techniques for creating a smaller version of an original document. An ontology is defined, and a document type for an original document is determined, based on the ontology. Multiple key-value pairs (KVPs) are extracted from the original document based on the document type. Pages in the original document that include one or more KVPs are identified, and the smaller, condensed version includes the identified pages from the original document.

Abstract: The present disclosure generally provides methods for identifying compounds that attenuate the bitter taste of plant proteins. In some particular aspects, the disclosure provides methods of identifying compounds that attenuate the bitter taste of plant proteins by determining whether the compounds modulate certain T2R bitter taste receptors. In some other aspects, the disclosure provides uses of such identified compounds to attenuate the bitter taste of an ingestible composition that comprises one or more plant proteins. In some further aspects, the disclosure provides flavored products, such as food or beverage products, that incorporate such ingestible compositions. Such food products include meat and dairy analogues.

Abstract: The present invention relates to anti-human metapneumovirus (hMPV) antibodies, as well as use of such antibodies in the treatment of viral infections. The invention also includes antigenic hMPV proteins and immunogenic compositions comprising such antigenic hMPV proteins, and the use of such antigenic hMPV proteins and related compositions for preventing or treating viral infection in a subject.

Abstract: The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.

Abstract: This application provides a screen casting method, a device, and a storage medium. In a screen casting process, when a sound output device is switched to the screen casting transmit end, whether the screen casting transmit end outputs a sound depends on a current status of an audio status switching control, thereby ensuring that whether the screen casting transmit end outputs a sound can be consistent with an expectation of a user in a screen casting scenario. In addition, in the screen casting method provided in this application, when whether the screen casting transmit end outputs a sound is set based on a click operation performed by the user on the audio status switching control, an icon corresponding to the audio status switching control is dynamically modified based on an audio status (mute or non-mute) corresponding to the audio status switching control.

Abstract: The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.

Abstract: This application provides a screen projection method, a device, and a storage medium. The method is applied to a screen projection transmit end on which a screen projection application is installed. In a screen projection scenario, an audio device currently used by the screen projection transmit end is obtained, and an identification number corresponding to the audio device is recorded in an audio device table. In this way, when it is determined that a sound output device selected by a user is a screen projection receive end, audio data is obtained from the audio device identified by the identification number and is sent to the screen projection receive end for play, to ensure that when the screen projection receive end is a sound output device, the screen projection receive end can always obtain the audio data and then play the audio data to output a sound.

Abstract: Herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.

Abstract: The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.

Abstract: The present disclosure generally provides compounds that antagonize certain T2R taste receptors, including related uses, methods, and compositions for the reduction of bitter taste and/or the enhancement of sweet taste. In certain aspects, the disclosure provides flavored articles or flavored compositions comprising such compounds, as well as uses of such compounds to reduce the bitter taste and/or enhance the sweet taste of such flavored articles or flavored compositions.

Abstract: The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.

Abstract: The present disclosure generally provides compounds that antagonize certain T2R taste receptors, including related uses, methods, and compositions for the reduction of bitter taste and/or the enhancement of sweet taste. In certain aspects, the disclosure provides flavored articles or flavored compositions comprising such compounds, as well as uses of such compounds to reduce the bitter taste and/or enhance the sweet taste of such flavored articles or flavored compositions.

Abstract: A method, computer system, and a computer program product is provided for generating a detailed thumbnail and/or preview of a content. In one embodiment the technique comprises analyzing data obtained from a content and classifying it according to a plurality of specific types. A plurality of key information may be then extracted from the data according to the classification. A plurality of key-values are correlated to the plurality of key information so as to provide a plurality of key-value pairs. These pairs are consolidated accordingly to generate a thumbnail and/or a preview that at least renders the key information provided by the consolidated key-value pairs as a rendering.

Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.